+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cerebrovascular Disease: Primary and Secondary Stroke Prevention

Cerebrovascular Disease: Primary and Secondary Stroke Prevention

Medical Clinics of North America 103(2): 295-308

Despite advances in earlier diagnosis and available aggressive treatments for vascular risk factors, stroke remains a leading cause of death and long-term disability worldwide. Disparities exist in stroke risk, rates of stroke, and treatment. Stroke is a heterogeneous disease with multiple additive risk factors and causes. Primary prevention of stroke focusing on risk factor modification plays an important role in reducing the burden of stroke in an aging population. Secondary prevention of recurrent strokes relies on the workup and a tailored treatment targeted at the mechanisms responsible for the incident stroke or transient ischemic attack.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066446764

Download citation: RISBibTeXText

PMID: 30704682

DOI: 10.1016/j.mcna.2018.10.001

Related references

Treatment of hypertension in primary and secondary prevention of cerebrovascular stroke. Vnitrni Lekarstvi 42(6): 426-431, 1996

Lifestye and primary and secondary prevention for cerebrovascular disease. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(2): 181-191, 2010

Treatment guidelines--primary and secondary prevention of stroke. From the Recommendations on Primary and Secondary Prevention of Stroke of the Medical Commission of the German Medical Society, July 1999. Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(5): 407-410, 2000

The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS trial. Seminars in Cerebrovascular Diseases and Stroke 3(3): 171-180, 2003

Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation. Value in Health 18(7): A374, 2015

Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. Schweizerische Medizinische Wochenschrift 125(51-52): 2479-2486, 1995

Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease. Journal of Vascular Surgery 50(2): 431-439, 2009

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. Health Technology Assessment 21(9): 1-386, 2017

Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study. Stroke 39(6): 1834-1843, 2008

Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease. Journal of Pediatric Health Care 31(2): 145-154, 2016

Secondary prevention of cardiovascular and cerebrovascular complications after ischemic stroke. Kardiologiia 54(5): 80-87, 2014

Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention. Stroke 41(9): 2102-2107, 2010

Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry. Stroke 32(12): 2860-2866, 2001

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. International Journal of Clinical Pharmacology and Therapeutics 41(12): 567-577, 2003

Stroke-Related Disease Comorbidity and Secondary Stroke Prevention Practices Among Young Stroke Survivors. Journal of Neuroscience Nursing 49(5): 296-301, 2017